Acute canine adenovirus 2 infection increases histamine airway reactivity in beagle puppies

Stuart F Quan, M. L. Witten, Roni Grad, Richard E Sobonya, C. G. Ray, N. N. Dambro, R. J. Lemen

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Acute infection with canine adenovirus was studied in 23 specific pathogen-free out-bred beagle puppies (median age = 78 days, range = 67 to 86 days) to determine its effects on pulmonary function and airway responsiveness to aerosolized histamine. The following groups were studied: uninoculated (n = 6, Control); inoculated with canine adenovirus type 2 (CAV2) (n = 11, Infected); and subclinical spontaneous infection with CAV2 (n = 6, Subclinical). While anesthetized with chloralose and mechanically ventilated, lung function and responsiveness to aerosolized histamine were measured 3 days before inoculation (Day -3), the day of inoculation (Day 0), and 3 to 4 (Day 3-4), 6 (Day 6), 8 to 10 (Day 8-10), and 12 to 14 (Day 12-14) days after inoculation. Histamine responsivness was assessed by calculating the provocation concentration of histamine diphosphate to increase lung resistance (RL) to 150% (PC 150% RL), or decrease dynamic lung compliance (Cdyn) to 75% (PC 75% Cdyn) of the response to saline [Rl(sal) and Cdyn(sal), respectively]. Arterial blood gases, functional residual capacity (FRC), specific static lung compliance (spCst), RL, Cdyn, and histamine responsiveness were not significantly different on Day 0 among the groups (p > 0.05). Control and Subclinical puppies remained healthy, had a mean weight gain of 0.7 kg, and did not change their histamine responsivness during the study period. Infected puppies developed moderate to severe clinical illnesses, had poor weight gain, and were histamine hyperresponsive on Days 3-4 and 6. One infected puppy died on Day 3-4, and two died on Day 6 of their illness. Light microscopic examination of their lungs showed severe bronchiolitis and pneumonia. In infected puppies, weight, FRC (n = 4), and arterial oxygen tension (n = 4) decreased by Day 6 from Day 0 values, but returned to normal by Day 12-14. Specific lung conductance (n = 4) and spCst (n = 4) did not change from Day 0 to Day 6. Baseline RL increased during the study in the Infected group, whereas there was a trend for it to decrease in Control and Subclinical puppies. Baseline Cdyn did not change in the Infected group, but increased in the Control and Subclinical puppies. Nevertheless, all puppies were asymptomatic by 14 days after inoculation and histamine responsiveness was not significantly different among groups. These studies suggest that clinical infection with CAV2 produces an increase in histamine responsiveness that parallels the severity and duration of the acute illness in specific pathogen-free beagle puppies.

Original languageEnglish (US)
Pages (from-to)414-420
Number of pages7
JournalAmerican Review of Respiratory Disease
Volume141
Issue number2 I
StatePublished - 1990

Fingerprint

Canine Adenoviruses
Adenoviridae Infections
Histamine
Lung
Lung Compliance
Specific Pathogen-Free Organisms
Functional Residual Capacity
Weight Gain
Chloralose
Bronchiolitis
Asymptomatic Infections
Infection
Pneumonia
Arterial Pressure
Gases
Oxygen
Light
Weights and Measures

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Acute canine adenovirus 2 infection increases histamine airway reactivity in beagle puppies. / Quan, Stuart F; Witten, M. L.; Grad, Roni; Sobonya, Richard E; Ray, C. G.; Dambro, N. N.; Lemen, R. J.

In: American Review of Respiratory Disease, Vol. 141, No. 2 I, 1990, p. 414-420.

Research output: Contribution to journalArticle

@article{ff65767f8856414292447f5f1783a698,
title = "Acute canine adenovirus 2 infection increases histamine airway reactivity in beagle puppies",
abstract = "Acute infection with canine adenovirus was studied in 23 specific pathogen-free out-bred beagle puppies (median age = 78 days, range = 67 to 86 days) to determine its effects on pulmonary function and airway responsiveness to aerosolized histamine. The following groups were studied: uninoculated (n = 6, Control); inoculated with canine adenovirus type 2 (CAV2) (n = 11, Infected); and subclinical spontaneous infection with CAV2 (n = 6, Subclinical). While anesthetized with chloralose and mechanically ventilated, lung function and responsiveness to aerosolized histamine were measured 3 days before inoculation (Day -3), the day of inoculation (Day 0), and 3 to 4 (Day 3-4), 6 (Day 6), 8 to 10 (Day 8-10), and 12 to 14 (Day 12-14) days after inoculation. Histamine responsivness was assessed by calculating the provocation concentration of histamine diphosphate to increase lung resistance (RL) to 150{\%} (PC 150{\%} RL), or decrease dynamic lung compliance (Cdyn) to 75{\%} (PC 75{\%} Cdyn) of the response to saline [Rl(sal) and Cdyn(sal), respectively]. Arterial blood gases, functional residual capacity (FRC), specific static lung compliance (spCst), RL, Cdyn, and histamine responsiveness were not significantly different on Day 0 among the groups (p > 0.05). Control and Subclinical puppies remained healthy, had a mean weight gain of 0.7 kg, and did not change their histamine responsivness during the study period. Infected puppies developed moderate to severe clinical illnesses, had poor weight gain, and were histamine hyperresponsive on Days 3-4 and 6. One infected puppy died on Day 3-4, and two died on Day 6 of their illness. Light microscopic examination of their lungs showed severe bronchiolitis and pneumonia. In infected puppies, weight, FRC (n = 4), and arterial oxygen tension (n = 4) decreased by Day 6 from Day 0 values, but returned to normal by Day 12-14. Specific lung conductance (n = 4) and spCst (n = 4) did not change from Day 0 to Day 6. Baseline RL increased during the study in the Infected group, whereas there was a trend for it to decrease in Control and Subclinical puppies. Baseline Cdyn did not change in the Infected group, but increased in the Control and Subclinical puppies. Nevertheless, all puppies were asymptomatic by 14 days after inoculation and histamine responsiveness was not significantly different among groups. These studies suggest that clinical infection with CAV2 produces an increase in histamine responsiveness that parallels the severity and duration of the acute illness in specific pathogen-free beagle puppies.",
author = "Quan, {Stuart F} and Witten, {M. L.} and Roni Grad and Sobonya, {Richard E} and Ray, {C. G.} and Dambro, {N. N.} and Lemen, {R. J.}",
year = "1990",
language = "English (US)",
volume = "141",
pages = "414--420",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2 I",

}

TY - JOUR

T1 - Acute canine adenovirus 2 infection increases histamine airway reactivity in beagle puppies

AU - Quan, Stuart F

AU - Witten, M. L.

AU - Grad, Roni

AU - Sobonya, Richard E

AU - Ray, C. G.

AU - Dambro, N. N.

AU - Lemen, R. J.

PY - 1990

Y1 - 1990

N2 - Acute infection with canine adenovirus was studied in 23 specific pathogen-free out-bred beagle puppies (median age = 78 days, range = 67 to 86 days) to determine its effects on pulmonary function and airway responsiveness to aerosolized histamine. The following groups were studied: uninoculated (n = 6, Control); inoculated with canine adenovirus type 2 (CAV2) (n = 11, Infected); and subclinical spontaneous infection with CAV2 (n = 6, Subclinical). While anesthetized with chloralose and mechanically ventilated, lung function and responsiveness to aerosolized histamine were measured 3 days before inoculation (Day -3), the day of inoculation (Day 0), and 3 to 4 (Day 3-4), 6 (Day 6), 8 to 10 (Day 8-10), and 12 to 14 (Day 12-14) days after inoculation. Histamine responsivness was assessed by calculating the provocation concentration of histamine diphosphate to increase lung resistance (RL) to 150% (PC 150% RL), or decrease dynamic lung compliance (Cdyn) to 75% (PC 75% Cdyn) of the response to saline [Rl(sal) and Cdyn(sal), respectively]. Arterial blood gases, functional residual capacity (FRC), specific static lung compliance (spCst), RL, Cdyn, and histamine responsiveness were not significantly different on Day 0 among the groups (p > 0.05). Control and Subclinical puppies remained healthy, had a mean weight gain of 0.7 kg, and did not change their histamine responsivness during the study period. Infected puppies developed moderate to severe clinical illnesses, had poor weight gain, and were histamine hyperresponsive on Days 3-4 and 6. One infected puppy died on Day 3-4, and two died on Day 6 of their illness. Light microscopic examination of their lungs showed severe bronchiolitis and pneumonia. In infected puppies, weight, FRC (n = 4), and arterial oxygen tension (n = 4) decreased by Day 6 from Day 0 values, but returned to normal by Day 12-14. Specific lung conductance (n = 4) and spCst (n = 4) did not change from Day 0 to Day 6. Baseline RL increased during the study in the Infected group, whereas there was a trend for it to decrease in Control and Subclinical puppies. Baseline Cdyn did not change in the Infected group, but increased in the Control and Subclinical puppies. Nevertheless, all puppies were asymptomatic by 14 days after inoculation and histamine responsiveness was not significantly different among groups. These studies suggest that clinical infection with CAV2 produces an increase in histamine responsiveness that parallels the severity and duration of the acute illness in specific pathogen-free beagle puppies.

AB - Acute infection with canine adenovirus was studied in 23 specific pathogen-free out-bred beagle puppies (median age = 78 days, range = 67 to 86 days) to determine its effects on pulmonary function and airway responsiveness to aerosolized histamine. The following groups were studied: uninoculated (n = 6, Control); inoculated with canine adenovirus type 2 (CAV2) (n = 11, Infected); and subclinical spontaneous infection with CAV2 (n = 6, Subclinical). While anesthetized with chloralose and mechanically ventilated, lung function and responsiveness to aerosolized histamine were measured 3 days before inoculation (Day -3), the day of inoculation (Day 0), and 3 to 4 (Day 3-4), 6 (Day 6), 8 to 10 (Day 8-10), and 12 to 14 (Day 12-14) days after inoculation. Histamine responsivness was assessed by calculating the provocation concentration of histamine diphosphate to increase lung resistance (RL) to 150% (PC 150% RL), or decrease dynamic lung compliance (Cdyn) to 75% (PC 75% Cdyn) of the response to saline [Rl(sal) and Cdyn(sal), respectively]. Arterial blood gases, functional residual capacity (FRC), specific static lung compliance (spCst), RL, Cdyn, and histamine responsiveness were not significantly different on Day 0 among the groups (p > 0.05). Control and Subclinical puppies remained healthy, had a mean weight gain of 0.7 kg, and did not change their histamine responsivness during the study period. Infected puppies developed moderate to severe clinical illnesses, had poor weight gain, and were histamine hyperresponsive on Days 3-4 and 6. One infected puppy died on Day 3-4, and two died on Day 6 of their illness. Light microscopic examination of their lungs showed severe bronchiolitis and pneumonia. In infected puppies, weight, FRC (n = 4), and arterial oxygen tension (n = 4) decreased by Day 6 from Day 0 values, but returned to normal by Day 12-14. Specific lung conductance (n = 4) and spCst (n = 4) did not change from Day 0 to Day 6. Baseline RL increased during the study in the Infected group, whereas there was a trend for it to decrease in Control and Subclinical puppies. Baseline Cdyn did not change in the Infected group, but increased in the Control and Subclinical puppies. Nevertheless, all puppies were asymptomatic by 14 days after inoculation and histamine responsiveness was not significantly different among groups. These studies suggest that clinical infection with CAV2 produces an increase in histamine responsiveness that parallels the severity and duration of the acute illness in specific pathogen-free beagle puppies.

UR - http://www.scopus.com/inward/record.url?scp=0025057266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025057266&partnerID=8YFLogxK

M3 - Article

C2 - 2154153

AN - SCOPUS:0025057266

VL - 141

SP - 414

EP - 420

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2 I

ER -